New York invests $65M in biotech with new clinical trial consortium and Biogenesis Park to compete with Boston, San Francisco ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Clinigen's Jules Shale discusses navigating complex logistics to deliver life-saving therapies and the rewarding human ...
Beyond Installation, Operational, and Performance Qualifications: A Risk-Based Validation Framework for AI-Driven Software in ...
AstraZeneca reports 88% emissions cut since 2015, crediting AI for accelerating drug discovery while embedding sustainability ...
Rentschler Biopharma, Syngene, and Symeres announce major leadership changes, appointing new CEOs and executives to drive ...
Sivakumar Kalidoss, BPI contributor ...
Pierre-Alain Ruffieux of Cytiva discusses key biotech trends including new modalities, AI adoption, supply chain stability, ...
VectorBuilder made an agreement with MaxCyte, a biotechnology and electroporation company. The partnership will focus on ...
KBI CSO Sigma Mostafa speaks with BioProcess International's Chris Spivey about the company's 30 years of partnering with ...
Shilpa Biologicals commissions ADC GMP plant in India, offering end-to-end drug substance manufacturing to meet FDA and EMA ...
AGC Biologics and Pyramid Pharma Services partner to offer integrated drug development and fill-finish services for US-based biopharmaceutical clients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results